FDCDDQ
SKYE icon

Federation des caisses Desjardins du Quebec’s Skye Bioscience SKYE Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio SKYE Stock Details SKYE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31 Hold
51
– – ﹤0.01% 2932
2025
Q4 		$38 Hold
51
– – ﹤0.01% 2840
2025
Q3 		$200 Hold
51
– – ﹤0.01% 2781
2025
Q2 		$213 Hold
51
– – ﹤0.01% 2632
2025
Q1 		$81 Hold
51
– – ﹤0.01% 2603
2024
Q4 		$144 Hold
51
– – ﹤0.01% 2468
2024
Q3 		$199 Hold
51
– – ﹤0.01% 2455
2024
Q2 		$409 Buy
+51
New +$605 ﹤0.01% 2274

Other funds holding SKYE

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Federation des caisses Desjardins du Quebec's SKYE Position: Q1 2026 in Review

Federation des caisses Desjardins du Quebec held its Skye Bioscience (SKYE) position steady in Q1 2026 at 51 shares worth $31. The position accounts for ﹤0.01% of the portfolio, ranked #2932.

Federation des caisses Desjardins du Quebec first reported a position in SKYE in Q2 2024 and has held it in 8 quarters since. The position peaked at $409 in Q2 2024. 39 funds tracked by Wall St. Rank hold SKYE as of Q1 2026.

  • Federation des caisses Desjardins du Quebec held 51 shares of Skye Bioscience worth $31 as of Q1 2026.
  • Federation des caisses Desjardins du Quebec left its Skye Bioscience share count unchanged in Q1 2026.
  • Skye Bioscience made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #2932 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Skye Bioscience in Q2 2024 and has held it in 8 quarters since.
  • Federation des caisses Desjardins du Quebec's Skye Bioscience position peaked at $409 in Q2 2024.
  • 39 funds tracked by Wall St. Rank held Skye Bioscience as of Q1 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.